Each of GHK-Cu, BPC-157 and TB-500 has its own separate body of published non-clinical literature, set out on each constituent product page
KL: Data curation, Formal analysis, Investigation, Validation, Writing original draft
Yes, nausea is the most common side effect, affecting 16-44% of patients depending on the formulation
In some cases, adjustments to the dosage or alternative treatments may be recommended
You cannot stop going out altogether, but you can take care of your skin
Clinical trials indicate that Orlistat, when used in conjunction with a reduced-calorie diet and increased physical activity, can lead to an average weight loss of approximately 5-8% of initial body weight over a year